Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bimin
- Development stage
- Unknown
- Lead developer
- Xiyuan Hospital
- Administration
- Oral
01
Overview
Bimin is a Traditional Chinese Medicine (TCM) capsule formulation developed by Xiyuan Hospital of the Chinese Academy of Traditional Chinese Medicine (now the China Academy of Chinese Medical Sciences). It is specifically designed for the treatment of allergic rhinitis. The drug is currently undergoing clinical evaluation, with a Phase I trial (ChiCTR1800017546) initiated to assess the safety and tolerability of single ascending doses in patients. As a botanical-based therapy, its mechanism likely involves the modulation of inflammatory pathways and immune responses associated with nasal hypersensitivity, common in TCM approaches to respiratory allergies.
- Brand names
- Bimin Capsule
- Other names
- Bimin capsuleBimin Jiaonang
02
Targets
IL8 (C-X-C Motif Chemokine Ligand 8)CCL20 (C-C motif chemokine ligand 20)CXCL2 (C-X-C motif chemokine ligand 2)IL1B (Interleukin-1 beta)
Beyond the preview
Go deeper on bimin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bimin.